Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.58 |
| ▸ | SLC5A2 | P31639 | 15/20 | 0.54 |
| ▸ | SLC5A1 | P13866 | 9/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29627364 | 0.87 | ATM (0.59) | ATMSLC5A2SLC5A1ALDH1A1 | |
| SCHEMBL29394990 | 0.87 | ATM (0.59) | ATMSLC5A2SLC5A1ALDH1A1 | |
| SCHEMBL29414951 | 0.87 | ATM (0.59) | ATMSLC5A2SLC5A1ALDH1A1 | |
| SCHEMBL285303 | 0.87 | ATM (0.59) | ATMSLC5A2SLC5A1ALDH1A1 | |
| SCHEMBL152361 | 0.87 | ATM (0.59) | ATMSLC5A2SLC5A1ALDH1A1 | |
| SCHEMBL9949259 | 0.87 | ATM (0.59) | ATMSLC5A2SLC5A1ALDH1A1 | |
| SCHEMBL29534778 | 0.87 | ATM (0.59) | ATMSLC5A2SLC5A1ALDH1A1 | |
| SCHEMBL153622 | 0.87 | ATM (0.59) | ATMSLC5A2SLC5A1ALDH1A1 | |
| SCHEMBL152362 | 0.87 | ATM (0.59) | ATMSLC5A2SLC5A1ALDH1A1 | |
| SCHEMBL1416327 | 0.87 | ATM (0.59) | ATMSLC5A2SLC5A1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004093909-A9 | METHODS TO REGULATE BIOFILM FORMATION | UNIV TECHNOLOGIES INT (CA) | 2005-01-20 | — | — | WO | disclosed |
| WO-2004093909-A1 | METHODS TO REGULATE BIOFILM FORMATION | UNIVERSITY TECHNOLOGIES INTERNATIONAL, INC. (CA) | 2004-11-04 | — | — | WO | disclosed |
| US-20040161849-A1 | Materials and methods relating to the transfer of nucleic acid into quiescent cells | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH, A MINNESOTA CORPORATION | 2004-08-19 | — | — | US | disclosed |
| US-6723561-B2 | POLYPEPTIDES | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 2004-04-20 | — | — | US | disclosed |
| US-20030007952-A1 | MATERIALS AND METHODS RELATING TO THE TRANSFER OF NUCLEIC ACID INTO QUIESCENT CELLS | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 2003-01-09 | — | — | US | disclosed |
| US-20010026939-A1 | Comprising a chimeric gene that expresses a polypeptide having insect toxicity properties of Bacillus thuringiensis crystal protein | RICE DOUGLAS (US) | 2001-10-04 | — | — | US | disclosed |
| US-6040504-A | A DNA MOLECULE COMPRISING OF A CODING REGION OF RIBULOSE BIPHOSPHATE CARBOXYLASE GENE; EXPRESSING IN COTTON CELLS A ENDOTOXIN THAT HAS THEINSECT TOXICITY PROPERTIES OF A CRYSTAL PROTEIN PRODUCED BY BACILLUS; FOR KILLING MOTH LARVAE | NOVARTIS FINANCE CORPORATION (US) | 2000-03-21 | — | — | US | disclosed |
| US-5196194-A | Vaccines containing Hepatitis B S-protein | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1993-03-23 | — | — | US | disclosed |
| EP-0020251-B1 | DNA TRANSFER VECTOR, HOST TRANSFORMED WITH IT, VACCINE, AND THEIR PRODUCTION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1993-01-13 | — | — | EP | disclosed |
| US-4935235-A | Hepatitis B | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1990-06-19 | — | — | US | disclosed |
| EP-0223247-A2 | Direct gene transfer into plastids and mitochondria | CIBA-GEIGY AG (CH) | 1987-05-27 | — | — | EP | disclosed |
| EP-0020251-A2 | DNA transfer vector, host transformed with it, vaccine, and their production | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1980-12-10 | — | — | EP | disclosed |